Providing Access to the Visual Environment

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv22
  2. Site contact updatedv21
  3. 2 versions Re-verified since Jun 14, 2023, no change to tracked fieldsv19-v20
  4. Study site revisedv18
  5. 4 versions Re-verified since Jan 24, 2018, no change to tracked fieldsv14-v17
Show 12 earlier versionsHide 12 earlier versions
  1. Primary completion date: Jan 2017 to Dec 2028
    • Study completion date: Dec 2018 to Dec 2028
    v13
  2. 2 versions Re-verified since Jun 1, 2015, no change to tracked fieldsv11-v12
  3. Site contact updatedv10
  4. Primary completion date: Jan 2017
    • Study completion date: Dec 2010 to Dec 2018
    v9
  5. 4 versions Re-verified since Aug 12, 2008, no change to tracked fieldsv5-v8
  6. Study completion date: Aug 2007 to Dec 2010v4
  7. Re-verified, no change to tracked fieldsv3
  8. Study completion date: Aug 2005 to Aug 2007v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Providing Access to the Visual Environment is a pediatric low vision grant which has the ability to provide comprehensive, interdisciplinary low vision rehabilitation services to every child in Tennessee with a vision impairment. Children, ages 3-21, with best-corrected vision of 20/50 or worse in the better seeing eye are prescribed optical devices to improve their visual functioning and trained to use the devices.
Trial Details
NCT Number NCT00341744
Lead Sponsor Vanderbilt University
Collaborators: Tennessee Department of Education
Conditions
(from sponsor)		 Vision Impairment
Related terms Acquired Immunodeficiency Syndrome, Vision Disorders
Enrollment 795 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov